...next ten years. The report outlines six trends that are anticipated to affect healthcare, based on data analysis of consumer demand, healthcare supply, and yield–the pricing where they intersect plus regulation and market incentives (e.g. reimbursement). This is a 30,000 foot view of an incredibly detailed report (details below): Price sensitivity and affordability concerns are reshaping demand. Prices have increased 54.5% from 2009 to 2023, compared to a 45.7% increase in overall consumer prices. Average annual insurer commercial plan premiums are up 85.7% between 2010 and 2024. Stakeholders are slow to adapt to changing demographic and lifestyle trends. US life... Continue Reading
Search Results for data breaches
Editor Donna is back. Here’s the catchup.
...clever acronym of the spelled-out 23andMe. The Bankruptcy Court of Missouri approved the sale on 7 July and it closed on 14 July, after no further bids from Regeneron. Interestingly, none of the articles mention Wojcicki’s backers. 23andMe release, CNBC, HIPAA Journal. To this Editor, selling a company back to the CEO who had full financial control over the company but augured a $6 billion valued company into Chapter 11–nosediving after bad investments, a major data breach and turmoil around its data and privacy–is beyond absurdity. I’m surprised that the bankruptcy judge even permitted it given the history, but she... Continue Reading
TTA’s Summer “Break”: On Hiatus
...UHG shareholders OK reduced package for CEO Hemsley, new ASTP/HIT-ONC leader, NJ’s Cooper Health patient data breach, Net Health buys Limber Health (Omada listing up on Friday, possibly) Anne Wojcicki asks 23andMe bankruptcy court to reopen bidding on 12 June with fresh offer (Why, Anne, why??) Two other views on UnitedHealth Group’s annus horribilis, for your consideration (Going inside the black box) Weekend reading/viewing (for me too): Rural telehealth blackouts and value-based care’s ‘utopia’ (Set aside the time) Should free-falling UnitedHealth Group be broken up? Or break itself up to survive, before it becomes another GE? (updated) (Not a rant,... Continue Reading
TTA’s Summer #1: Hims buys Zava for EU/UK, Omada’s IPO, Wojcicki tries harder to buy 23andMe, UnitedHealth’s miseries explored, Centene sued on AZ network, more!
...uncovers inaccurate provider ‘ghost networks’. This just in: Hims acquires Zava, adds 1.3 million European/UK telemed customers (A way to grow and defy the bears?) Need to knows: Omada’s $158M IPO at flat valuation, AZ lawsuit on Centene plan’s ‘ghost network’ fatality, UHG shareholders OK reduced package for CEO Hemsley, new ASTP/HIT-ONC leader, NJ’s Cooper Health patient data breach, Net Health buys Limber Health (Omada listing up on Friday, possibly) Anne Wojcicki asks 23andMe bankruptcy court to reopen bidding on 12 June with fresh offer (Why, Anne, why??) Two other views on UnitedHealth Group’s annus horribilis, for your consideration (Going... Continue Reading
Need to knows: Omada’s $158M IPO at flat valuation, AZ lawsuit on Centene plan’s ‘ghost network’ fatality, UHG shareholders OK reduced package for CEO Hemsley, new ASTP/HIT-ONC leader, NJ’s Cooper Health patient data breach, Net Health buys Limber Health
...ASTP and also as a Senior Advisor to the Deputy Secretary of HHS. Among other duties, he was an administrator of the COVID-19 Provider Relief Fund and lead the development of the AHRQ National Nursing Home COVID Action Network. ASTP oversees Federal technology, data and artificial intelligence policy. More changes may be coming as Secretary Robert F. Kennedy Jr. will be reorganizing most areas of HHS. FedScoop, Healthcare Dive Moving north to Camden, NJ, last March the Cooper Health system detected a data breach dating back to 2024. Personal health information (PHI) was apparently “accessed and acquired” without permission by... Continue Reading
Anne Wojcicki asks 23andMe bankruptcy court to reopen bidding on 12 June with fresh offer (updated with $305M bid)
...offer from TTAM along with a $10 million termination fee. FierceBiotech One wonders where the egos shake out. Regeneron Pharmaceuticals has sound reasons for acquiring 23andMe’s genomic data to add to its developing genomics research. The price, based on our own estimate of over 10.85 million users left providing consent, was generous on a per-user basis. But you really do have to wonder why Anne Wojcicki cannot let go and say ‘enough’. This Editor, while not a mindreader nor an attorney, believes that the Missouri court may look upon Ms. Wojcicki’s new filing with a severely jaundiced eye. There was... Continue Reading
TTA’s Unofficial Summer kickoff: breaking up UnitedHealth to save it, post-GLP-1 weight gain, soft robots, NZ telehealth controversy, Midi Health widening women’s health, AssistIQ, Ambience, more!
...out the VA/Oracle EHR in ‘waves’, Fuze Health formed from LetsGetChecked/Truepill, hacking and ransomware 92% of PHI data breaches (A renaming of a 2024 ‘arranged marriage’–can it be saved?) News roundup: Hinge Health public @$32/share, lower valuation. Is WeightWatchers game over? Calibrate replaces CEO, new prez for Oak Street, NMC gets ‘Smarter’ rolling up 3 portfolio companies, another splash of investor ‘cold water’ (The first health tech IPO in 2 years and ‘smushing’ when they can’t) Update: Masimo’s website status and an analysis of the Sound United sale (Getting up and running post-attack, but what happened?) 23andMe sold to Regeneron... Continue Reading
News roundup: GLP-1 weight regain real, soft robots walk off 3D printer, Ambience’s AI coding beats doctors by 27%, Get a Second Opinion debuts, $11.5M for AssistIQ
...interactions, alternatives, and cost. Its two tools are: Discovery Tool: Analyzes a single medication and/or condition against a unique profile, generating a comprehensive report with rankings, supporting data, and average monthly cost—often identifying more effective alternatives with fewer side effects at a lower cost. The annual plan covers up to 10 reports. Planner: Evaluates up to 10 medications treating up to 10 conditions simultaneously, identifying optimal treatment combinations while minimizing side effects and adverse interactions. The annual plan covers up to two reports. The profile is built using their AI Diagnostician engine, which analyzes age, sex, BMI, medications, pre-existing conditions,... Continue Reading
Job Posting: Yosi Health seeks Demand Generation Manager and Manager, Data Analytics & Reporting
...meetings to study the situation and explores out-of-box ideas, then you may be the person to lead Yosi Health’s demand generation efforts. For more details and to apply, see their Careers section and the job listing here. Manager, Data Analytics & Reporting This position oversees data collection, analysis, reporting and infrastructure maintenance to help gain valuable insights to make business decisions. It is a full-time position, hybrid and based in their NYC office. About the Role – Is this You? As Manager of Data Analytics & Reporting, you will play a central role in shaping Yosi Health’s data strategy —... Continue Reading
Should free-falling UnitedHealth Group be broken up? Or break itself up to survive, before it becomes another GE? (updated)
...now is the US’ fourth-largest firm by revenues, just behind Walmart, Amazon, and Apple. (Visual Capitalist 17 Dec 2024, based on American Medical Association data). Their growth has been led by acquisition into Optum, their health services division. It houses their owned physician practices as the largest owner of practices in the US with 90,000 physicians, their ACO relationships, data analytics, Change Healthcare, the largest billing and claims management company, home care/hospice, the third largest PBM Optum Rx, a venture investment arm, and much more. Optum is the massive symbol of the integration envisioned by former and current CEO Stephen... Continue Reading
Most Recent Comments